Can a pharmacist check-in boost medication adherence in diabetes and kidney disease?

NCT ID NCT04190251

Completed Disease control Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests a support program for people with type 2 diabetes and chronic kidney failure who struggle to take their medications regularly. Participants receive an electronic pill bottle that tracks when they open it, plus short motivational interviews with a pharmacist. The goal is to see if this combination helps them stick to their medication routine over 6 to 12 months, compared to usual care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Interprofessional medication adherence support program (IMAP) combining electronic monitoring and motivational interviews
What this could lead to: If successful, this program could offer a practical way to help patients with diabetes and kidney disease stick to their medications, potentially improving health outcomes.
What could go wrong: This is a small, single-center study with 73 participants, so results may not apply broadly. The program requires extra pharmacy visits, which may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome diabetes mellitus Medication Adherence type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2 RENAL INSUFFICIENCY, CHRONIC

Contacts and locations

Show contact details

Locations

Centre Hospitalier Universitaire Vaudois

Lausanne, Canton of Vaud, 1011, Switzerland
Unisante

Lausanne, Canton of Vaud, 1011, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.